Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
29.22
Dollar change
+0.18
Percentage change
0.62
%
IndexRUT P/E37.67 EPS (ttm)0.78 Insider Own2.87% Shs Outstand46.48M Perf Week-0.24%
Market Cap1.36B Forward P/E8.21 EPS next Y3.56 Insider Trans-8.21% Shs Float45.16M Perf Month-2.31%
Income41.95M PEG3.62 EPS next Q0.65 Inst Own106.02% Short Float9.02% Perf Quarter-14.84%
Sales674.98M P/S2.01 EPS this Y0.08% Inst Trans2.38% Short Ratio8.02 Perf Half Y-5.86%
Book/sh18.72 P/B1.56 EPS next Y26.54% ROA2.58% Short Interest4.07M Perf Year-26.79%
Cash/sh5.99 P/C4.88 EPS next 5Y10.40% ROE5.10% 52W Range25.93 - 48.60 Perf YTD-13.40%
Dividend Est.- P/FCF9.74 EPS past 5Y- ROI2.92% 52W High-39.88% Beta0.76
Dividend TTM- Quick Ratio4.17 Sales past 5Y15.46% Gross Margin64.15% 52W Low12.69% ATR (14)1.02
Dividend Ex-Date- Current Ratio5.24 EPS Y/Y TTM155.39% Oper. Margin12.94% RSI (14)46.48 Volatility3.31% 3.70%
Employees712 Debt/Eq0.67 Sales Y/Y TTM1.22% Profit Margin6.22% Recom1.20 Target Price45.30
Option/ShortYes / Yes LT Debt/Eq0.65 EPS Q/Q316.94% Payout0.00% Rel Volume1.12 Prev Close29.04
Sales Surprise0.35% EPS Surprise0.76% Sales Q/Q5.40% EarningsFeb 29 BMO Avg Volume507.79K Price29.22
SMA20-1.52% SMA50-3.46% SMA200-10.25% Trades Volume569,631 Change0.62%
Date Action Analyst Rating Change Price Target Change
Mar-07-24Resumed JP Morgan Overweight $80 → $45
Dec-20-23Initiated Raymond James Outperform $42
Aug-03-23Upgrade TD Cowen Market Perform → Outperform $50
Jan-31-23Resumed Wedbush Outperform $88 → $60
Oct-21-22Resumed Jefferies Buy $66
Jan-03-22Resumed JP Morgan Overweight $75 → $83
Jul-26-21Upgrade JP Morgan Neutral → Overweight $75
Apr-21-21Resumed JP Morgan Neutral $70
Apr-09-21Initiated Berenberg Buy $93
Apr-07-21Resumed RBC Capital Mkts Outperform $86
Mar-14-24 08:23AM
Mar-13-24 07:00AM
Mar-08-24 11:55PM
Mar-06-24 08:00AM
Mar-04-24 08:28PM
08:38AM Loading…
Mar-01-24 08:38AM
06:05AM
12:28AM
Feb-29-24 10:00AM
09:15AM
08:32AM
08:26AM
08:00AM
Feb-22-24 08:00AM
Feb-15-24 08:36AM
08:00AM Loading…
Feb-07-24 08:00AM
Feb-01-24 10:45AM
Jan-05-24 12:21PM
Jan-04-24 05:00PM
Jan-03-24 08:00AM
Dec-21-23 07:30AM
Dec-06-23 11:13AM
Nov-13-23 10:10AM
Nov-10-23 07:30AM
Nov-07-23 08:00AM
Nov-04-23 10:28AM
Nov-02-23 12:34PM
10:00AM
08:23AM
08:00AM
08:00AM Loading…
Oct-26-23 08:00AM
Oct-12-23 08:00AM
Oct-10-23 08:00AM
Oct-02-23 08:00AM
Sep-27-23 12:07PM
11:50AM
Sep-26-23 04:30PM
Sep-06-23 08:00AM
Aug-03-23 10:03AM
Aug-02-23 12:45PM
08:11AM
08:00AM
Jul-28-23 02:56PM
Jul-26-23 08:00AM
Jun-21-23 08:00PM
Jun-02-23 11:31AM
May-31-23 08:00AM
May-09-23 08:00AM
May-03-23 11:42PM
05:25PM
03:11PM
08:11AM
08:00AM
Apr-26-23 08:00PM
08:00AM
Apr-20-23 09:20AM
08:00AM
Apr-19-23 08:00AM
Apr-12-23 08:00AM
Apr-03-23 08:00AM
Mar-30-23 11:30AM
Mar-29-23 08:00AM
Mar-27-23 08:00AM
Mar-24-23 08:50AM
Mar-22-23 08:00AM
Mar-09-23 09:17AM
Mar-08-23 08:00AM
Feb-28-23 11:39PM
08:00AM
Feb-23-23 08:00AM
Feb-21-23 08:00AM
Jan-05-23 04:30PM
Jan-04-23 08:00AM
Dec-20-22 10:06AM
Dec-13-22 08:00AM
Nov-18-22 01:38PM
Nov-17-22 08:05AM
Nov-14-22 08:00AM
Nov-09-22 05:14AM
Nov-08-22 08:00AM
Nov-04-22 10:54AM
Nov-03-22 09:15AM
08:00AM
Nov-01-22 10:01AM
Oct-27-22 10:02AM
Oct-20-22 08:00AM
Oct-15-22 08:34AM
Oct-13-22 08:00AM
Oct-07-22 02:10PM
Sep-27-22 08:00AM
Sep-21-22 06:04PM
10:08AM
08:00AM
Sep-20-22 08:00AM
Sep-13-22 08:00AM
Sep-08-22 10:42AM
Sep-07-22 11:07AM
07:00AM
Sep-02-22 11:31AM
Aug-10-22 08:00AM
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PACE GARY WDirectorMar 08 '24Sale30.6090,0002,754,00022,127Mar 08 05:33 PM
PACE GARY WDirectorMar 07 '24Sale30.8128,257870,598112,127Mar 08 05:33 PM
PACE GARY WDirectorMar 06 '24Sale29.671,06631,628140,384Mar 08 05:33 PM
WINSTON ROYChief Medical OfficerAug 02 '23Sale34.8850917,75152,440Aug 04 04:47 PM
Riker Lauren BullaroSenior Vice President, FinanceJul 05 '23Sale38.9164325,01922,687Jul 07 08:04 PM
Riker Lauren BullaroSenior Vice President, FinanceJun 14 '23Sale38.426,366244,60622,687Jun 16 05:39 PM
Williams Kristen MarieChief Administrative OfficerJun 14 '23Sale37.036,467239,47325,375Jun 16 05:42 PM
Kronenfeld Mark A.DirectorJun 08 '23Option Exercise29.9015,000448,50032,897Jun 12 04:16 PM
Kronenfeld Mark A.DirectorJun 08 '23Sale37.0415,000555,60017,897Jun 12 04:16 PM
STACK DAVID MCEO and ChairmanJun 07 '23Sale37.875,326201,669153,781Jun 07 09:33 PM
WINSTON ROYChief Medical OfficerJun 07 '23Sale37.871,85770,31541,356Jun 07 09:36 PM
Reinhart Charles A. IIIChief Financial OfficerJun 07 '23Sale37.871,37151,91333,626Jun 07 09:29 PM
Williams Kristen MarieChief Administrative OfficerJun 07 '23Sale37.871,35751,38320,892Jun 07 09:34 PM
Ellis Ronald J. Jr.Chief Strategy OfficerJun 07 '23Sale37.871,16243,99930,909Jun 07 09:20 PM
REINHARDT MAXPresident, Rest of WorldJun 07 '23Sale37.871,09941,61429,225Jun 07 09:28 PM
McLoughlin DennisChief Customer OfficerJun 07 '23Sale37.871,05740,02338,115Jun 07 09:24 PM
GAUGLER DARYLChief Operating OfficerJun 07 '23Sale37.871,04739,64521,539Jun 07 09:22 PM
Riker Lauren BullaroSenior Vice President, FinanceJun 07 '23Sale37.8761623,32519,053Jun 07 09:31 PM
SLONIN JONATHANChief Clinical OfficerJun 07 '23Sale37.8749018,55436,323Jun 07 09:32 PM
STACK DAVID MCEO and ChairmanJun 06 '23Sale38.995,058197,216159,107Jun 07 09:33 PM
MOLLOY ANTHONYChief Lgl & Compliance OfficerJun 06 '23Sale38.554,521174,28512,877Jun 07 09:26 PM
WINSTON ROYChief Medical OfficerJun 06 '23Sale38.991,77969,36543,213Jun 07 09:36 PM
Williams Kristen MarieChief Administrative OfficerJun 06 '23Sale38.991,30150,72722,249Jun 07 09:34 PM
Reinhart Charles A. IIIChief Financial OfficerJun 06 '23Sale38.991,23648,19334,997Jun 07 09:29 PM
Ellis Ronald J. Jr.Chief Strategy OfficerJun 06 '23Sale38.991,11443,43632,071Jun 07 09:20 PM
REINHARDT MAXPresident, Rest of WorldJun 06 '23Sale38.991,05441,09730,324Jun 07 09:28 PM
McLoughlin DennisChief Customer OfficerJun 06 '23Sale38.991,01439,53739,172Jun 07 09:24 PM
GAUGLER DARYLChief Operating OfficerJun 06 '23Sale38.991,00539,18622,586Jun 07 09:22 PM
Riker Lauren BullaroSenior Vice President, FinanceJun 06 '23Sale38.9959123,04419,669Jun 07 09:31 PM
SLONIN JONATHANChief Clinical OfficerJun 06 '23Sale38.9947118,36536,813Jun 07 09:32 PM
MOLLOY ANTHONYChief Lgl & Compliance OfficerJun 05 '23Sale38.282,26786,77417,398Jun 07 09:26 PM
GAUGLER DARYLChief Operating OfficerJun 05 '23Sale38.741,00038,74023,591Jun 07 09:22 PM
Brege LauraDirectorJun 05 '23Sale38.7460023,2449,547Jun 07 09:18 PM
HASTINGS PAUL JDirectorJun 05 '23Sale38.3458022,2376,599Jun 07 09:23 PM
GAUGLER DARYLChief Operating OfficerMay 31 '23Option Exercise34.002,50085,00026,894Jun 02 06:28 PM
GAUGLER DARYLChief Operating OfficerMay 31 '23Sale39.082,50097,70024,591Jun 02 06:28 PM
HASTINGS PAUL JDirectorMay 15 '23Option Exercise29.907,000209,30014,179May 17 04:07 PM
HASTINGS PAUL JDirectorMay 15 '23Sale41.857,000292,9507,179May 17 04:07 PM
PACE GARY WDirectorMay 11 '23Option Exercise29.907,000209,300144,690May 15 06:53 PM
PACE GARY WDirectorMay 11 '23Sale41.785,015209,527139,675May 15 06:53 PM
Brege LauraDirectorApr 03 '23Option Exercise29.907,000209,30017,147Apr 05 04:34 PM
Brege LauraDirectorApr 03 '23Sale40.727,000285,04010,147Apr 05 04:34 PM
Last Close
Mar 28 04:00PM ET
0.8908
Dollar change
+0.0016
Percentage change
0.18
%
AMRN Amarin Corp ADR daily Stock Chart
Index- P/E- EPS (ttm)-0.15 Insider Own0.44% Shs Outstand408.82M Perf Week3.40%
Market Cap364.18M Forward P/E- EPS next Y-0.13 Insider Trans-1.08% Shs Float407.04M Perf Month-32.52%
Income-59.26M PEG- EPS next Q-0.03 Inst Own23.55% Short Float4.47% Perf Quarter-1.04%
Sales308.22M P/S1.18 EPS this Y6.67% Inst Trans-7.25% Short Ratio8.15 Perf Half Y-2.78%
Book/sh1.35 P/B0.66 EPS next Y9.52% ROA-6.90% Short Interest18.19M Perf Year-41.78%
Cash/sh0.79 P/C1.13 EPS next 5Y38.90% ROE-10.33% 52W Range0.65 - 1.58 Perf YTD2.39%
Dividend Est.- P/FCF- EPS past 5Y17.93% ROI-10.57% 52W High-43.62% Beta1.99
Dividend TTM- Quick Ratio1.80 Sales past 5Y14.60% Gross Margin53.00% 52W Low36.84% ATR (14)0.06
Dividend Ex-Date- Current Ratio2.80 EPS Y/Y TTM44.82% Oper. Margin-18.41% RSI (14)42.80 Volatility5.15% 7.45%
Employees275 Debt/Eq0.02 Sales Y/Y TTM-16.19% Profit Margin-19.23% Recom3.00 Target Price1.08
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-780.95% Payout- Rel Volume0.52 Prev Close0.89
Sales Surprise12.76% EPS Surprise62.83% Sales Q/Q-17.11% EarningsFeb 29 BMO Avg Volume2.23M Price0.89
SMA20-1.13% SMA50-17.63% SMA200-10.24% Trades Volume1,153,032 Change0.18%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Underweight
Oct-25-23Downgrade Jefferies Buy → Hold $3 → $1
Jan-06-23Upgrade Jefferies Hold → Buy $1.30 → $3
May-06-22Downgrade JP Morgan Neutral → Underweight
May-05-22Downgrade SVB Leerink Outperform → Mkt Perform $10 → $3
May-05-22Downgrade H.C. Wainwright Buy → Neutral $10 → $3
May-04-22Downgrade Northland Capital Outperform → Market Perform
May-12-21Downgrade Goldman Neutral → Sell $6 → $5
Sep-29-20Resumed JP Morgan Neutral
Aug-26-20Initiated Piper Sandler Overweight $21
Mar-25-24 08:00AM
Mar-01-24 09:30AM
08:39AM
Feb-29-24 03:30PM
07:37AM
07:34AM Loading…
07:34AM
07:00AM
Feb-15-24 08:00AM
Jan-22-24 07:30AM
Jan-12-24 09:40AM
Jan-11-24 09:34AM
Jan-10-24 07:02PM
07:00AM
Dec-26-23 07:13PM
Dec-11-23 08:00AM
12:00PM Loading…
Dec-05-23 12:00PM
Nov-12-23 09:00AM
Nov-02-23 10:58AM
Nov-01-23 12:30PM
12:03PM
09:30AM
09:25AM
07:30AM
07:00AM
Oct-31-23 12:00PM
Oct-26-23 08:00AM
Oct-23-23 10:08AM
Oct-19-23 08:00AM
Sep-12-23 08:00AM
Aug-24-23 09:29AM
11:22AM Loading…
Aug-19-23 11:22AM
Aug-09-23 04:05PM
Aug-08-23 07:00AM
Aug-07-23 07:00AM
Aug-03-23 11:22AM
Aug-02-23 07:33AM
07:11AM
Jul-31-23 08:00AM
Jul-28-23 02:56PM
Jul-26-23 08:00AM
Jul-25-23 04:05PM
Jul-20-23 08:00AM
Jul-19-23 12:58PM
11:19AM
Jul-18-23 04:16PM
04:15PM
Jul-05-23 11:43AM
Jun-21-23 09:00AM
Jun-08-23 11:07AM
Jun-01-23 04:30PM
06:00AM
May-23-23 09:50AM
May-12-23 11:00AM
May-03-23 02:00PM
01:47PM
07:41AM
07:00AM
May-02-23 01:32PM
Apr-19-23 08:00AM
Apr-17-23 07:00AM
Apr-13-23 10:18AM
Apr-12-23 09:18AM
Apr-04-23 03:53PM
08:00AM
Mar-16-23 08:00AM
Mar-06-23 04:05PM
09:37AM
08:00AM
Mar-05-23 10:21AM
Mar-03-23 11:09AM
Mar-02-23 01:23PM
11:44AM
05:55AM
Mar-01-23 11:02AM
11:00AM
07:00AM
Feb-28-23 11:11AM
10:39AM
10:38AM
08:00AM
Feb-27-23 04:29PM
08:00AM
07:15AM
Feb-24-23 11:52AM
Feb-22-23 04:50PM
08:00AM
Feb-21-23 08:30AM
08:00AM
Feb-20-23 01:00PM
Feb-17-23 09:03AM
07:30AM
Feb-16-23 04:05PM
12:34PM
09:44AM
Feb-15-23 04:29PM
Feb-14-23 05:09PM
09:55AM
Feb-13-23 07:47PM
09:40AM
08:00AM
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holt PatrickPresident and CEOJan 22 '24Buy1.0914,42615,724314,426Jan 24 04:31 PM
Ketchum Steven BChief Scientific OfficerDec 12 '23Sale0.7934,13126,963566,100Dec 14 06:35 PM
Holt PatrickPresident and CEOAug 16 '23Buy1.04300,000312,315300,000Aug 16 07:51 PM